Condensed Consolidated Statements of Cash Flows (Unaudited) € in Millions, $ in Millions		3 Months Ended
		Mar. 31, 2019 USD ($)	Mar. 31, 2018 USD ($)
OPERATING ACTIVITIES
Net income		$ 1.0	$ 6.3
Less: Income from discontinued operations		0.0	1.6
Income from continuing operations		1.0	4.7
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization		16.0	12.7
Interest accretion of convertible notes discount		1.8	2.5
Employee share-based compensation expense		2.4	2.9
Financing costs amortization		0.4	0.3
Unrealized foreign currency transaction gain		(0.3)	(0.4)
Other non-cash operating activities		2.5	1.2
Changes in assets and liabilities, net of acquisitions:
Accounts receivable		(12.2)	15.6
Inventory		(10.4)	(19.5)
Unbilled contract revenues and other assets		(11.2)	7.4
Accounts payable and other liabilities		(20.7)	(20.8)
Customer advances and billings in excess of contract revenue		(2.5)	13.4
Net Cash (Used In) Provided By Operating Activities		(33.2)	20.0
INVESTING ACTIVITIES
Capital expenditures		(5.9)	(6.2)
Acquisition of businesses, net of cash acquired		(2.8)	(12.5)
Government grants		(0.2)	0.1
Net Cash Used In Investing Activities		(8.9)	(18.6)
FINANCING ACTIVITIES
Borrowings on revolving credit facilities		18.8	38.0
Repayments on revolving credit facilities		(27.0)	(26.8)
Payments for debt issuance costs		0.0	(0.3)
Proceeds from exercise of stock options		8.3	1.3
Common stock repurchases		(2.7)	(2.2)
Net Cash (Used In) Provided By Financing Activities		(2.6)	10.0
DISCONTINUED OPERATIONS
Cash Provided By Operating Activities	[1]	0.0	3.0
Cash Used In Investing Activities	[2]	0.0	(0.4)
Cash Provided By Discontinued Operations		0.0	2.6
Effect of exchange rate changes on cash and cash equivalents		(1.5)	3.9
Net (decrease) increase in cash, cash equivalents, restricted cash, and restricted cash equivalents		(46.2)	17.9
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period	[3]	119.1	131.4
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD	[3]	$ 72.9	$ 149.3

[1] Includes depreciation expense of $0.4 and amortization expense of $0.6 for the three months ended March 31, 2018.

[2] Includes capital expenditures of $0.4 for the three months ended March 31, 2018 .

[3] Includes restricted cash and restricted cash equivalents of $1.0 in other assets at March 31, 2019 and $6.5 ($5.5 in other current assets and $1.0 in other assets) at March 31, 2018. Includes restricted cash and restricted cash equivalents of $1.0 in other assets at December 31, 2018. For further information regarding restricted cash and restricted cash equivalents balances, refer to Note 7, “Debt and Credit Arrangements.”